Literature DB >> 8334360

Update on skeletal muscle ventricles as aortic diastolic counterpulsators.

H Nakajima1, G A Thomas, H O Nakajima, R L Hammond, R Fietsam, F W Mocek, T L Hooper, H Lu, A D Spanta, L W Stephenson.   

Abstract

Skeletal muscle ventricles are constructed from canine latissimus dorsi muscle. These skeletal muscle ventricles can be placed subcutaneously on the chest wall or inside the chest cavity. Skeletal muscle ventricles are connected to the descending thoracic aorta and activated to pump blood as aortic diastolic counterpulsators. The skeletal muscle ventricle in 1 animal pumped blood in the circulation for 27 months. Skeletal muscle ventricles can also function effectively under the condition of low cardiac output. Although thrombus has been detected in some skeletal muscle ventricles, thromboembolism to distal organs has been detected only rarely during the past few years. This research appears promising; however, skeletal muscle ventricle rupture remains a problem and currently accounts for about 30% of the mortality in the long-term experiments. It occurs at the site between the skeletal muscle ventricle outlet and the Dacron sewing ring that is necessary to connect conduits from the skeletal muscle ventricle to the animal's circulation. We believe that skeletal muscle ventricle rupture is likely to be a solvable problem. Once a solution has been found, skeletal muscle ventricles may be ready for clinical use in patients with chronic congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334360      PMCID: PMC325071     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  18 in total

1.  Significance of impulse activity in the transformation of skeletal muscle type.

Authors:  S Salmons; F A Sréter
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

2.  Implantable rate-responsive counterpulsation assist system.

Authors:  C M Li; A Hill; M Colson; C Desrosiers; R C Chiu
Journal:  Ann Thorac Surg       Date:  1990-03       Impact factor: 4.330

3.  The muscle-powered dual-chamber counterpulsator: rheologically superior implantable cardiac assist device.

Authors:  G Kochamba; C Desrosiers; M Dewar; R C Chiu
Journal:  Ann Thorac Surg       Date:  1988-06       Impact factor: 4.330

4.  Implantable extra-aortic balloon assist powered by transformed fatigue-resistant skeletal muscle.

Authors:  R C Chiu; G L Walsh; M L Dewar; J H De Simon; A S Khalafalla; D Ianuzzo
Journal:  J Thorac Cardiovasc Surg       Date:  1987-11       Impact factor: 5.209

5.  Hydraulic pouches of canine latissimus dorsi. Potential for left ventricular assistance.

Authors:  J D Mannion; R Hammond; L W Stephenson
Journal:  J Thorac Cardiovasc Surg       Date:  1986-04       Impact factor: 5.209

6.  Myocardial substitution with a stimulated skeletal muscle: first successful clinical case.

Authors:  A Carpentier; J C Chachques
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

7.  Autogenously lined skeletal muscle ventricles in circulation. Up to nine months' experience.

Authors:  D R Anderson; A Pochettino; R L Hammond; E Hohenhaus; A D Spanta; C R Bridges; S Lavine; R D Bhan; M Colson; L W Stephenson
Journal:  J Thorac Cardiovasc Surg       Date:  1991-04       Impact factor: 5.209

8.  Skeletal muscle ventricles in circulation. One to eleven weeks' experience.

Authors:  M A Acker; W A Anderson; R L Hammond; A J Chin; J W Buchanan; C C Morse; A M Kelly; L W Stephenson
Journal:  J Thorac Cardiovasc Surg       Date:  1987-08       Impact factor: 5.209

9.  Histochemical and fatigue characteristics of conditioned canine latissimus dorsi muscle.

Authors:  J D Mannion; T Bitto; R L Hammond; N A Rubinstein; L W Stephenson
Journal:  Circ Res       Date:  1986-02       Impact factor: 17.367

10.  Effects of collateral blood vessel ligation and electrical conditioning on blood flow in dog latissimus dorsi muscle.

Authors:  J D Mannion; M Velchik; R Hammond; A Alavi; T Mackler; S Duckett; M Staum; S Hurwitz; W Brown; L W Stephenson
Journal:  J Surg Res       Date:  1989-10       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.